RANK Ligand Inhibitor protects the Bone

被引：0
|
作者：
Hausmann, Ralph
机构：
来源：
ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE | 2012年 / 150卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [1] Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin
    Li, Xiaodong
    Ominsky, Michael S.
    Stolina, Marina
    Warmington, Kelly S.
    Geng, Zhaopo
    Niu, Qing-Tian
    Asuncion, Frank J.
    Tan, Hong-Lin
    Grisanti, Mario
    Dwyer, Denise
    Adamu, Steven
    Ke, Hua Zhu
    Simonet, W. Scott
    Kostenuik, Paul J.
    [J]. BONE, 2009, 45 (04) : 669 - 676
  • [2] Place of rank ligand inhibitor in giant cell tumour of bone
    Kerboua, Esma
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
    Yee, Andrew J.
    Raje, Noopur S.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2012, 7 : 331 - 338
  • [4] Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data
    Dempster, David W.
    Lambing, Cheryl L.
    Kostenuik, Paul J.
    Grauer, Andreas
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (03) : 521 - 536
  • [5] Denosumab, a RANK ligand Inhibitor, leads to Mineralization of an Intracortical Aneurysmal Bone Cyst
    Modaressi, Kourosh
    Bode-Lesniewska, Beata
    Fuchs, Bruno
    [J]. SWISS MEDICAL WEEKLY, 2014, 144 : 53S - 53S
  • [6] Use of zoledronic acid and a RANK ligand inhibitor in the palliative treatment of cancers of the prostate with bone metastases
    Mushigin, S. V.
    Sokov, D. G.
    Rusakov, I. G.
    [J]. ONKOUROLOGIYA, 2013, 9 (04): : 52 - 54
  • [7] Bone Biology and the Role of the RANK Ligand Pathway
    Murthy, Rashmi K.
    Morrow, P. K.
    Theriault, Richard L.
    [J]. ONCOLOGY-NEW YORK, 2009, 23 (14): : 9 - 15
  • [8] Inhibition of RANK Ligand to treat bone metastases
    Body, Jean-Jacques
    [J]. BULLETIN DU CANCER, 2013, 100 (11) : 1207 - 1213
  • [9] RANK ligand and osteoprotegerin in myeloma bone disease
    Sezer, O
    Heider, U
    Zavrski, I
    Kühne, CA
    Hofbauer, LC
    [J]. BLOOD, 2003, 101 (06) : 2094 - 2098
  • [10] Denosumab, a RANK Ligand Inhibitor, for Postmenopausal Women with Osteoporosis
    Sutton, Emily E.
    Riche, Daniel M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (7-8) : 1000 - 1009
12345